8637 (8637) Fair Value & Analysis

Industrials · Market cap HK$526M

8 8637 8637 · HK

PriceHK$3.51

Fair ValueHK$2.72

Upside-22.5%

Quality56/100

Watch 8637 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$2.04 – HK$3.40

Fair value as of: Jul 3, 2026

From 24 valuation models · updated today

Share price −12.7% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.8200 – HK$4.07 · fair‑value band HK$2.04 – HK$3.40 · the HK$3.51 price screens above the HK$2.72 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

8637 (8637) currently trades at HK$3.51, while our model-based Fair Value estimate is HK$2.72 — implying the stock looks roughly 22.5% overvalued today. We read business quality at 56/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 8637 generated revenue of HK$47.6M at a net margin of 21.2%. Revenue grew 19.4% year over year. It earns a return on equity of 16.9%. Net debt stands at HK$32.1M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) HK$47.6M

Revenue growth (YoY) +19.4%

Net margin 21.2%

Return on equity 16.9%

Free cash flow HK$42.0M FY2025

P/E ratio 0.8

More key figures

Operating margin 8.9%

EPS (TTM) HK$0.0200

EPS growth (YoY) +536%

Net debt HK$32.1M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

8637 reported revenue of HK$284M in FY2025 versus HK$111M in FY2021, a compound +26.4%/yr. Reported net income was HK$60.3M in FY2025.

Revenue +26.4%/yr

FY21 HK$111M

FY22 HK$222M

FY23 HK$38.8M

FY24 HK$215M

FY25 HK$284M

Net income

FY21 −HK$15.5M

FY22 HK$18.1M

FY23 HK$27.3M

FY24 HK$18.2M

FY25 HK$60.3M

Is 8637 fairly valued? → Check now

Similar stocks

6 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock	Price	Fair Value	vs Fair Value
GE Vernova Inc GEV	$1,128	$185.61	-84%
SIEGY SIEGY	$155.06	$89.54	-42%
SMAWF SMAWF	$307.12	$176.28	-43%
SMNS SMNS	C$31.76	C$22.85	-28%
SIE SIE	€279.00	€140.38	-50%
Schneider Electric S.E. SBGSF	$334.00	$148.44	-56%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 8637 (8637) undervalued?

As of Jul 3, 2026, our model estimates a fair value of HK$2.72 versus a price of HK$3.51 — about −23% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 8637?

Our model-based fair value for 8637 is HK$2.72 (as of Jul 3, 2026), built from audited fundamentals. The current price is HK$3.51.

What is the quality score of 8637?

8637 has a Quality Score of 56/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 8637 (8637)?

8637 reported trailing-twelve-month revenue of about HK$47.6M (latest available figure, as of Jul 3, 2026).

What is the net profit margin of 8637?

The net profit margin of 8637 is about 21.2%, meaning it keeps roughly 21.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.